Advances in Therapeutic Applications of Fish Oil, 2nd Edition

Dear Colleagues,

The World Health Organization estimates that cardiovascular disease (CVD) remains the number one cause of death worldwide, and the residual risk after implementing all current therapies is still high. It is thus crucial that all health professionals make appropriate use of all the available intervention strategies to control risk factors. Although genetic factors and aging are important in determining the overall risk, a substantial proportion of CVD occurs in conjunction with a series of modifiable risk factors, such as hyperlipidemia, hypertension, obesity, insulin resistance and diabetes, susceptible to lifestyle modifications, which include dietary improvement, adequate physical activity and the use of functional foods, food supplements and drugs. Emerging research has explored the application of natural food-based strategies in disease management. With marine species comprising approximately half of the global biodiversity, the ocean offers a wonderful resource for novel compounds, which may serve to improve the health of the worldwide population. Many of the positive effects of fish, including those on dyslipidemia and heart disease, have been attributed to fish oil, and more specifically to n-3 PUFAs, i.e., EPA and DHA.

As with the first edition that was closed in 2021 (https://www.mdpi.com/journal/marinedrugs/special_issues/fish_oil), the aim of this Special Issue is to gather new information regarding the novel therapeutic applications of fish oil. In addition, this research topic intends to update information about the use of fish oil in CVD and other human diseases.

Dr. Cinzia Parolini
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.